Filing Details
- Accession Number:
- 0001645470-19-000029
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-08 12:36:16
- Reporting Period:
- 2019-05-02
- Accepted Time:
- 2019-05-08 12:36:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645470 | Brian Alan Collier | 6320 Canoga Avenue 15Th Floor Woodland Hills CA 91367 | Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-02 | 33,737 | $0.01 | 21,370,860 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-02 | 66,263 | $0.01 | 21,437,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-02 | 5,000 | $0.01 | 21,442,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-02 | 3,200 | $0.01 | 21,445,323 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-02 | 24,800 | $0.01 | 21,470,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-02 | 10,000 | $0.01 | 21,480,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-02 | 18,000 | $0.01 | 21,498,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-02 | 2,000 | $0.01 | 21,500,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-02 | 5,000 | $0.01 | 21,505,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-02 | 5,000 | $0.01 | 21,510,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-03 | 5,000 | $0.01 | 21,515,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-03 | 1,904 | $0.01 | 21,517,027 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-03 | 23,096 | $0.01 | 21,540,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-03 | 5,000 | $0.01 | 21,545,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-03 | 20,000 | $0.01 | 21,565,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-06 | 5,000 | $0.01 | 21,570,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-06 | 5,000 | $0.01 | 21,575,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-06 | 5,000 | $0.01 | 21,580,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-06 | 5,000 | $0.01 | 21,585,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-06 | 5,000 | $0.01 | 21,590,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-06 | 2,000 | $0.01 | 21,592,123 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
